Skip to content
value.today

Nocion Therapeutics, Inc.

🇺🇸 Waltham, Massachusetts, USAPharmaceuticalsFounded 2017

Formerly Carica Health, Inc.

Total raised
$76 M
4 rounds on record
Latest round
$23 M
Dec 2025
First round on record
Jan 2021
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Nocion Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2025$23 MNo. 4$10 to $50 million

Nocion Therapeutics, Inc.: Raise no. 4, Dec 2025

Investors in this round

13 investors had bought by the notice of Mar 13, 2026: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James Ellis · Executive Officer
  • Matthew Frankel · Executive Officer
  • Peter Courossi · Executive Officer
  • Richard Batycky · Executive Officer, Director
  • Freddie Dear · Director
  • Julie Grant · Director
  • Michael Higgins · Director
  • Pini Orbach · Director
  • Rosy Hu · Director
  • Vijay Murthy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard P Batycky, Ceo. Newest notice filed Mar 13, 2026. Read the notice at the SEC.

equitySEC
Feb 2024$31 MNo. 3$10 to $50 million

Nocion Therapeutics, Inc.: Raise no. 3, Feb 2024

Investors in this round

13 investors had bought by the notice of Mar 13, 2024: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $70 M offered; $39 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernard Silverman · Executive Officer
  • James Ellis · Executive Officer
  • Peter Courossi · Executive Officer
  • Richard Batycky · Executive Officer, Director
  • Freddie Dear · Director
  • Julie Grant · Director
  • Michael Higgins · Director
  • Pini Orbach · Director
  • Rosy Hu · Director
  • Vijay Murthy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard P Batycky, Ceo. Newest notice filed Mar 13, 2024. Read the notice at the SEC.

equitySEC
Aug 2021$7 MNo. 2$2 to $10 million

Nocion Therapeutics, Inc.: Raise no. 2, Aug 2021

Investors in this round

10 investors had bought by the notice of Aug 24, 2022: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $17 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bridget M. Cole · Executive Officer
  • Christopher M. Silber · Executive Officer
  • James M. Ellis · Executive Officer
  • Jonathan Papanek Garen · Executive Officer
  • Michael M. Lipp · Executive Officer
  • Richard Batycky · Executive Officer, Director
  • Jessica M. Alston · Director
  • Julie Papanek Grant · Director
  • Meredith M. Fisher · Director
  • Michael Papanek Higgins · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Batycky, Ceo. Newest notice filed Aug 24, 2022 (1 amendment). Read the notice at the SEC.

equitySEC
Jan 2021$15 MNo. 1$10 to $50 million

Nocion Therapeutics, Inc.: Raise no. 1, Jan 2021

Investors in this round

11 investors had bought by the notice of Jan 22, 2021: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $25 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bridget M. Cole · Executive Officer
  • Christopher M. Silber · Executive Officer
  • James M. Ellis · Executive Officer
  • Michael M. Lipp · Executive Officer
  • Richard Batycky · Executive Officer, Director
  • Jessica M. Alston · Director
  • Julie Papanek Grant · Director
  • Meredith M. Fisher · Director
  • Michael Papanek Higgins · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard P Batycky, Ceo. Newest notice filed Jan 22, 2021. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Nocion Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2026).

    SEC Form D · Mar 2026

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Mar 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Nocion Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Nocion Therapeutics, Inc.
NameRoleNamed in
James EllisExecutive officerMar 2026
Matthew FrankelExecutive officerMar 2026
Peter CourossiExecutive officerMar 2026
Richard BatyckyExecutive officerMar 2026
Bernard SilvermanExecutive officerMar 2024
Bridget M. ColeExecutive officerAug 2022
Christopher M. SilberExecutive officerAug 2022
James M. EllisExecutive officerAug 2022
Jonathan Papanek GarenExecutive officerAug 2022
Michael M. LippExecutive officerAug 2022
Freddie DearDirectorMar 2026
Julie GrantDirectorMar 2026
Michael HigginsDirectorMar 2026
Pini OrbachDirectorMar 2026
Richard BatyckyDirectorMar 2026
Rosy HuDirectorMar 2026
Vijay MurthyDirectorMar 2026
Jessica M. AlstonDirectorAug 2022
Julie Papanek GrantDirectorAug 2022
Meredith M. FisherDirectorAug 2022
Michael Papanek HigginsDirectorAug 2022